Porteus, Matthew, Md
Clinical trials sponsored by Porteus, Matthew, Md, explained in plain language.
-
Experimental stem cell transplant could reduce toxic side effects for fanconi anemia patients
Disease control Recruiting nowThis study tests a new way to treat Fanconi Anemia, a rare genetic disorder that causes bone marrow failure. Doctors will give patients donor stem cells that have been specially filtered to remove certain immune cells, along with an experimental antibody called JSP191. The goal i…
Phase: PHASE1, PHASE2 • Sponsor: Porteus, Matthew, MD • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New cell therapy aims to supercharge immune recovery in young cancer patients
Disease control Recruiting nowThis early-phase study tests whether a special cell therapy called T-allo10 can safely help rebuild the immune system in children and young adults (up to age 45) with blood cancers who have received a stem cell transplant. The treatment is given after the transplant to speed up r…
Phase: PHASE1 • Sponsor: Porteus, Matthew, MD • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC